Christine Palma, DPM
Foot & Ankle Surgery · Lake Charles, LANPI 1932696754
Payments from drug & device makers
What this record shows
Stryker accounts for 94.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $2,094 and has fallen 77.7% since, to $467 in 2025.
Across 30 payments — averaging $99.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Amgen$73
- Linvatec Corporation$43
- Bioventus LLC$17
- Paratek Pharmaceuticals, Inc.$14
- Smith+Nephew$12
What the payments were for
- Travel & lodging$1,54151%
- Food & beverage$1,45249%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 23 | $2,833 |
| Amgen(2 entities) | 3 | $73 |
| Linvatec Corporation | 1 | $43 |
| Bioventus LLC | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,992 in reported general payments places this provider in the 55th percentile of 92 foot & ankle surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 62 | $1,324 |
| Ciclopirox | 30 | $1,076 |
| Diclofenac Sodium | 16 | $920 |
| Clotrimazole | 19 | $424 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $165 |
| Methylprednisolone | 18 | $157 |
| Cephalexin | 27 | $125 |
| Gabapentin | 12 | $106 |
| Clindamycin Hcl | 12 | $79 |
| Meloxicam | 26 | $61 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Lake Charles
- Tyson GreenLake Charles$203K
- Bradley JimersonLake Charles$11K
- Daniel HallLake Charles$7K
- Marcus SoileauLake Charles$5K
- John PourciauLake Charles$4K
- Sydney RudyLake Charles$2K
- Estuardo SilvaLake Charles$1K
- Mallory PrzybylskiLake Charles$1K
- Brian BensonLeesville$278K
- Meredith WarnerBaton Rouge$232K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.